Promising Medical Stocks Worth Watching - November 22nd

Gilead Sciences logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Gilead Sciences, McKesson, and Medtronic were highlighted as medical stocks to watch after ranking among the sector’s highest in recent dollar trading volume.
  • On Friday, Gilead shares slipped $0.20 to $166.33 and Medtronic fell $0.73 to $99.88, while McKesson gained $7.15 to $1,069.31.
  • The companies span different areas of healthcare: Gilead develops medicines, McKesson distributes pharmaceuticals and provides related services, and Medtronic makes medical devices and therapies.
  • Interested in Gilead Sciences? Here are five stocks we like better.

Gilead Sciences, McKesson, and Medtronic are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. “Medical stocks” are shares of companies involved in healthcare, such as pharmaceutical and biotechnology firms, medical-device makers, and healthcare providers. Investors may buy them to gain exposure to the healthcare industry, though their performance can depend on factors like regulation, clinical-trial results, and healthcare demand. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

NASDAQ:GILD traded down $0.20 during trading hours on Friday, hitting $166.33. 7,554,884 shares of the stock were exchanged, compared to its average volume of 6,363,988. The company has a current ratio of 1.38, a quick ratio of 1.22 and a debt-to-equity ratio of 1.84. The firm's fifty day moving average price is $157.26 and its 200 day moving average price is $142.46. The company has a market cap of $206.30 billion, a P/E ratio of -52.64 and a beta of 0.35. Gilead Sciences has a 52-week low of $116.88 and a 52-week high of $176.58.

Read Our Latest Research Report on GILD

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

MCK stock traded up $7.15 during midday trading on Friday, reaching $1,069.31. The stock had a trading volume of 869,451 shares, compared to its average volume of 710,413. McKesson has a 52-week low of $723.68 and a 52-week high of $1,121.50. The company's fifty day simple moving average is $974.65 and its 200 day simple moving average is $880.71. The company has a market cap of $123.46 billion, a price-to-earnings ratio of 27.50, a price-to-earnings-growth ratio of 1.81 and a beta of 0.27.

Read Our Latest Research Report on MCK

Medtronic (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Shares of MDT stock traded down $0.73 on Friday, hitting $99.88. 9,033,491 shares of the stock traded hands, compared to its average volume of 7,261,612. Medtronic has a twelve month low of $73.31 and a twelve month high of $106.33. The stock has a market capitalization of $127.75 billion, a PE ratio of 24.60, a PEG ratio of 2.34 and a beta of 0.56. The firm's 50-day moving average price is $94.62 and its two-hundred day moving average price is $88.45. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.54 and a current ratio of 2.07.

Read Our Latest Research Report on MDT

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Gilead Sciences Right Now?

Before you consider Gilead Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gilead Sciences wasn't on the list.

While Gilead Sciences currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines